These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

587 related items for PubMed ID: 15970632

  • 1. Treatment of end-of-dose wearing-off in parkinson's disease: stalevo (levodopa/carbidopa/entacapone) and levodopa/DDCI given in combination with Comtess/Comtan (entacapone) provide equivalent improvements in symptom control superior to that of traditional levodopa/DDCI treatment.
    Brooks DJ, Agid Y, Eggert K, Widner H, Ostergaard K, Holopainen A, TC-INIT Study Group.
    Eur Neurol; 2005; 53(4):197-202. PubMed ID: 15970632
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of combining levodopa with entacapone on quality of life and activities of daily living in patients experiencing wearing-off type fluctuations.
    Reichmann H, Boas J, Macmahon D, Myllyla V, Hakala A, Reinikainen K, ComQol Study Group.
    Acta Neurol Scand; 2005 Jan; 111(1):21-8. PubMed ID: 15595934
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Long term experience with Stalevo in Szeged, Hungary].
    Klivényi P, Vécsei L.
    Ideggyogy Sz; 2009 May 30; 62(5-6):178-80. PubMed ID: 19579666
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Levodopa/carbidopa/entacapone in Parkinson's disease.
    Seeberger LC, Hauser RA.
    Expert Rev Neurother; 2009 Jul 30; 9(7):929-40. PubMed ID: 19589043
    [Abstract] [Full Text] [Related]

  • 8. Quality of life in early Parkinson's disease treated with levodopa/carbidopa/entacapone.
    Fung VS, Herawati L, Wan Y, Movement Disorder Society of Australia Clinical Research and Trials Group, QUEST-AP Study Group.
    Mov Disord; 2009 Jan 15; 24(1):25-31. PubMed ID: 18846551
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Double-blind, placebo-controlled study of entacapone in levodopa-treated patients with stable Parkinson disease.
    Olanow CW, Kieburtz K, Stern M, Watts R, Langston JW, Guarnieri M, Hubble J, US01 Study Team.
    Arch Neurol; 2004 Oct 15; 61(10):1563-8. PubMed ID: 15477510
    [Abstract] [Full Text] [Related]

  • 14. Entacapone/levodopa/carbidopa combination tablet: Stalevo.
    Drugs R D; 2003 Oct 15; 4(5):310-1. PubMed ID: 12952501
    [Abstract] [Full Text] [Related]

  • 15. Cost-effectiveness of levodopa/carbidopa/entacapone (Stalevo) compared to standard care in UK Parkinson's disease patients with wearing-off.
    Findley LJ, Lees A, Apajasalo M, Pitkänen A, Turunen H.
    Curr Med Res Opin; 2005 Jul 15; 21(7):1005-14. PubMed ID: 16004667
    [Abstract] [Full Text] [Related]

  • 16. Levodopa/DDCI and entacapone is the preferred treatment for Parkinson's disease patients with motor fluctuations in routine practice: a retrospective, observational analysis of a large French cohort.
    Damier P, Viallet F, Ziegler M, Bourdeix I, Rerat K.
    Eur J Neurol; 2008 Jul 15; 15(7):643-8. PubMed ID: 18582341
    [Abstract] [Full Text] [Related]

  • 17. [Inhibition of the COMPT with entacapone in the treatment of motor fluctuations in Parkinson disease].
    Kulisevsky J.
    Neurologia; 1999 Jul 15; 14(7):349-58. PubMed ID: 10570622
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
    Prescrire Int; 2005 Apr 15; 14(76):51-4. PubMed ID: 15875340
    [Abstract] [Full Text] [Related]

  • 20. Early versus delayed initiation of entacapone in levodopa-treated patients with Parkinson's disease: a long-term, retrospective analysis.
    Nissinen H, Kuoppamäki M, Leinonen M, Schapira AH.
    Eur J Neurol; 2009 Dec 15; 16(12):1305-11. PubMed ID: 19570145
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.